EUVIMEDEUVIMED entdecken
Open Access

Neuritin’s potential as a new therapeutic target for diverse autoimmune diseases

Wen Zeng, Di Yu, Pablo F Canete

Molecular Therapy · 2026-08 · 34 (8) · 4379-4381

DOI: 10.1016/j.ymthe.2026.07.014 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Therapy, 2026-08. Verfasst von Wen Zeng und 2 weiteren Autor:innen. Beteiligte Einrichtung: Frazer Institute, Faculty of Health Medicine and Behavioural Science, The University of Queensland, Brisbane, QLD, Australia. Die Arbeit nennt 11 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHMRC.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Frazer Institute, Faculty of Health Medicine and Behavioural Science, The University of Queensland, Brisbane, QLD, Australia.
  • Frazer Institute, Faculty of Health Medicine and Behavioural Science, The University of Queensland, Brisbane, QLD, Australia; Ian Frazer Centre for Children's Immunotherapy Research, Child Health Research Centre, Facult…

Förderung

  • NHMRC

Zitieren

APA

Zeng, W., Yu, D., & Canete, P. F. (2026). Neuritin’s potential as a new therapeutic target for diverse autoimmune diseases. Molecular Therapy, 34(8), 4379-4381. https://doi.org/10.1016/j.ymthe.2026.07.014

Vancouver

Zeng W, Yu D, Canete PF. Neuritin’s potential as a new therapeutic target for diverse autoimmune diseases. Molecular Therapy. 2026;34(8):4379-4381. doi:10.1016/j.ymthe.2026.07.014

BibTeX
@article{Zeng2026,
  author = {Zeng, Wen and Yu, Di and Canete, Pablo F},
  title = {Neuritin’s potential as a new therapeutic target for diverse autoimmune diseases},
  journal = {Molecular Therapy},
  year = {2026},
  volume = {34},
  number = {8},
  pages = {4379--4381},
  doi = {10.1016/j.ymthe.2026.07.014}
}
Kostenlos starten →